This public procurement record has 1 release in its history.

Planning

29 Jun 2026 at 14:09

Summary of the contracting process

NHS Blood and Transplant (NHSBT) is in the planning stage for a procurement process titled "Clean Room Requalification," within the services category. The process pertains to the Clinical Biotechnology Centre (CBC) located in Bristol, UK, and is a part of NHSBT's Cellular and Molecular Therapies function. The primary industry category is technical inspection and testing services. NHSBT has scheduled an early market engagement, inviting interested parties to engage with supplier meetings happening the week commencing 27th July 2026. Interested organisations should contact the buyer by 17th July 2026. Although a formal procurement process isn't guaranteed, further tender details are anticipated by September 2026.

This tender offers significant opportunities for businesses specialising in technical testing, analysis, and consultancy services, especially small and medium-sized enterprises as they are particularly suited for the contract. This procurement allows businesses to engage in the healthcare sector, contributing to clinical-grade therapy production, crucial for targeting conditions like cancer and genetic diseases. With an estimated contract value of £96,000 inclusive of taxes and a proposed duration from November 2026 to November 2029, this tender presents a long-term growth opportunity in a field supporting advances in the UK life sciences sector.

How relevant is this notice?

Notice Title

Clean Room Requalification

Notice Description

NHS Blood and Transplant (NHSBT) have a requirement for Clean Room Requalification. The Clinical Biotechnology Centre (CBC) at NHS Blood and Transplant (NHSBT) is a specialist facility that manufactures plasmids and viral vectors for early-stage clinical trials targeting incurable diseases like cancer and genetic disorders. Operating as part of NHSBT's Cellular and Molecular Therapies function, the CBC supports the UK life sciences sector by translating laboratory research into clinical-grade therapies. The manufacture of sterile products or tissues should be carried out in clean areas, entry to which is through change rooms/air locks/transfer hatches for personnel/equipment and materials. These classified environments MUST be monitored and achieve the appropriate current GMP regulatory specifications for that environment as detailed in EudraLex volume 4 "The rules governing medicinal products in the European Union" Annex 1 Manufacture of sterile medicinal products. Classification and Re-qualification is performed at a minimum annually At Rest, except for particle counts which are performed At Rest and In Operation.

Planning Information

NHSBT wishes to invite those organisations who express an interest in this opportunity to Supplier engagement meetings to be held on-line via Microsoft Teams during w/c 27th July 2026. Any interested organisations are asked to contact carley.butcher@nhsbt.nhs.uk by no later than 17:00 on the 17th July 2026 to express their interest. If you do not respond by this date, you are not excluded from participating in the forthcoming tender, this date is to allow for optional supplier engagement meetings to be organised. There is no guarantee that a formal procurement process will be launched as a result of this early market engagement exercise, nor that any contract(s) will be placed. No remuneration or compensation etc will be paid to organisations who take part in this early market engagement exercise. Suppliers should take part in this process only on the basis that they fully understand and accept this position. Further information e.g. draft technical specification, award criteria and timescales may be released for consultation purposes only, to organisations who express an interest in this notice. Please note that all details are subject to change.

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-06bf4b
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/060844-2026
Current Stage
Planning
All Stages
Planning

Procurement Classification

Notice Type
UK2 - Preliminary Market Engagement Notice
Procurement Type
Standard
Procurement Category
Services
Procurement Method
Not Specified
Procurement Method Details
Not specified
Tender Suitability
SME
Awardee Scale
Not specified

Common Procurement Vocabulary (CPV)

CPV Divisions

71 - Architectural, construction, engineering and inspection services


CPV Codes

71600000 - Technical testing, analysis and consultancy services

71630000 - Technical inspection and testing services

71631000 - Technical inspection services

Notice Value(s)

Tender Value
£80,000 Under £100K
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
Not specified

Notice Dates

Publication Date
29 Jun 20262 weeks ago
Submission Deadline
Not specified
Future Notice Date
21 Sep 20263 months to go
Award Date
Not specified
Contract Period
2 Nov 2026 - 1 Nov 2029 3-4 years
Recurrence
Not specified

Notice Status

Tender Status
Planning
Lots Status
Planning
Awards Status
Not Specified
Contracts Status
Not Specified

Contracting Authority (Buyer)

Main Buyer
NHS BLOOD AND TRANSPLANT
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
BRISTOL
Postcode
BS34 7QH
Post Town
Bristol
Country
England

Major Region (ITL 1)
TLK South West (England)
Basic Region (ITL 2)
TLK5 West of England
Small Region (ITL 3)
TLK52 Bath & North East Somerset and South Gloucestershire
Delivery Location
Not specified

Local Authority
South Gloucestershire
Electoral Ward
Filton
Westminster Constituency
Filton and Bradley Stoke

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-h6vhtk-06bf4b-2026-06-29T15:09:21+01:00",
    "date": "2026-06-29T15:09:21+01:00",
    "ocid": "ocds-h6vhtk-06bf4b",
    "initiationType": "tender",
    "parties": [
        {
            "id": "GB-PPON-PDBY-6395-VWBP",
            "name": "NHS Blood and Transplant",
            "identifier": {
                "scheme": "GB-PPON",
                "id": "PDBY-6395-VWBP"
            },
            "address": {
                "streetAddress": "500 North Bristol Park",
                "locality": "Bristol",
                "postalCode": "BS34 7QH",
                "country": "GB",
                "countryName": "United Kingdom",
                "region": "UKK12"
            },
            "contactPoint": {
                "name": "Carley Butcher",
                "email": "carley.butcher@nhsbt.nhs.uk"
            },
            "roles": [
                "buyer"
            ],
            "details": {
                "url": "https://www.nhsbt.nhs.uk/",
                "classifications": [
                    {
                        "id": "publicAuthorityCentralGovernment",
                        "scheme": "UK_CA_TYPE",
                        "description": "Public authority - central government"
                    }
                ]
            }
        }
    ],
    "buyer": {
        "id": "GB-PPON-PDBY-6395-VWBP",
        "name": "NHS Blood and Transplant"
    },
    "planning": {
        "milestones": [
            {
                "id": "engagement",
                "type": "engagement",
                "description": "NHSBT wishes to invite those organisations who express an interest in this opportunity to Supplier engagement meetings to be held on-line via Microsoft Teams during w/c 27th July 2026. Any interested organisations are asked to contact carley.butcher@nhsbt.nhs.uk by no later than 17:00 on the 17th July 2026 to express their interest. If you do not respond by this date, you are not excluded from participating in the forthcoming tender, this date is to allow for optional supplier engagement meetings to be organised. There is no guarantee that a formal procurement process will be launched as a result of this early market engagement exercise, nor that any contract(s) will be placed. No remuneration or compensation etc will be paid to organisations who take part in this early market engagement exercise. Suppliers should take part in this process only on the basis that they fully understand and accept this position. Further information e.g. draft technical specification, award criteria and timescales may be released for consultation purposes only, to organisations who express an interest in this notice. Please note that all details are subject to change.",
                "dueDate": "2026-07-17T23:59:59+01:00",
                "status": "scheduled"
            }
        ],
        "documents": [
            {
                "id": "060844-2026",
                "documentType": "marketEngagementNotice",
                "noticeType": "UK2",
                "description": "Preliminary market engagement notice on Find a Tender",
                "url": "https://www.find-tender.service.gov.uk/Notice/060844-2026",
                "datePublished": "2026-06-29T15:09:21+01:00",
                "format": "text/html"
            }
        ]
    },
    "tender": {
        "id": "C455532",
        "legalBasis": {
            "id": "2023/54",
            "scheme": "UKPGA",
            "uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents"
        },
        "title": "Clean Room Requalification",
        "description": "NHS Blood and Transplant (NHSBT) have a requirement for Clean Room Requalification. The Clinical Biotechnology Centre (CBC) at NHS Blood and Transplant (NHSBT) is a specialist facility that manufactures plasmids and viral vectors for early-stage clinical trials targeting incurable diseases like cancer and genetic disorders. Operating as part of NHSBT's Cellular and Molecular Therapies function, the CBC supports the UK life sciences sector by translating laboratory research into clinical-grade therapies. The manufacture of sterile products or tissues should be carried out in clean areas, entry to which is through change rooms/air locks/transfer hatches for personnel/equipment and materials. These classified environments MUST be monitored and achieve the appropriate current GMP regulatory specifications for that environment as detailed in EudraLex volume 4 \"The rules governing medicinal products in the European Union\" Annex 1 Manufacture of sterile medicinal products. Classification and Re-qualification is performed at a minimum annually At Rest, except for particle counts which are performed At Rest and In Operation.",
        "items": [
            {
                "id": "1",
                "additionalClassifications": [
                    {
                        "scheme": "CPV",
                        "id": "71630000",
                        "description": "Technical inspection and testing services"
                    },
                    {
                        "scheme": "CPV",
                        "id": "71631000",
                        "description": "Technical inspection services"
                    },
                    {
                        "scheme": "CPV",
                        "id": "71600000",
                        "description": "Technical testing, analysis and consultancy services"
                    }
                ],
                "deliveryAddresses": [
                    {
                        "region": "UK",
                        "country": "GB",
                        "countryName": "United Kingdom"
                    }
                ],
                "relatedLot": "1"
            }
        ],
        "value": {
            "amountGross": 96000,
            "amount": 80000,
            "currency": "GBP"
        },
        "mainProcurementCategory": "services",
        "aboveThreshold": false,
        "lots": [
            {
                "id": "1",
                "suitability": {
                    "sme": true
                },
                "contractPeriod": {
                    "startDate": "2026-11-02T00:00:00Z",
                    "endDate": "2029-11-01T23:59:59Z",
                    "maxExtentDate": "2030-11-01T23:59:59Z"
                },
                "hasRenewal": true,
                "status": "planning"
            }
        ],
        "communication": {
            "futureNoticeDate": "2026-09-21T23:59:59+01:00"
        },
        "status": "planning"
    },
    "language": "en"
}